Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfacalcidol and Irbesartan in Type 2 Diabetic Nephropathy
NCT03147677Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jul 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfacalcidol in diabetic nephropathy (DN), sponsored by Third Xiangya Hospital, Central South University. Started Jul 2016; status: completed.
02
Drugs
alfacalcidol
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03147677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03147677.